May 04, 2015 8:50am EDT Can-Fite subsidiary, OphthaliX, Signs Term Sheet to Acquire Improved Vision Systems Ltd.
Apr 27, 2015 7:00am EDT Can-Fite Reports Positive Results from Further Analysis of Phase II/III Psoriasis Trial
Apr 20, 2015 7:00am EDT Can-Fite Applies for Orphan Drug Designation in Europe for CF102 in the Treatment of Liver Cancer
Mar 30, 2015 9:11am EDT Can-Fite Reports Top-Line Results from Phase II/III Trial for CF101 in Treatment of Psoriasis
Mar 23, 2015 7:00am EDT Can-Fite Signs Multi-Million Dollar Distribution Agreement for CF101 in Canada with Cipher Pharmaceuticals
Mar 18, 2015 7:00am EDT Can-Fite Completes Development of Commercial Biomarker Test to Predict Patients' Response to Company Drugs
